Descriptions

The FcsRI-mediated calcium signal pathway is not affected by DHS but shows an inhibition when subjected to EGTA treatment, impacting the activation and signaling pathway.

Autoinhibitory domains (AIDs)

Target domain

47-302 (Protein kinase domain)

Relief mechanism

Partner binding

Assay

Structural analysis

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q16980

Entry ID Method Resolution Chain Position Source
1KOB X-ray 230 A A/B 5-376 PDB
AF-Q16980-F1 Predicted AlphaFoldDB

No variants for Q16980

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q16980

No associated diseases with Q16980

3 regional properties for Q16980

Type Name Position InterPro Accession
domain Protein kinase domain 47 - 302 IPR000719
active_site Serine/threonine-protein kinase, active site 164 - 176 IPR008271
domain Immunoglobulin I-set 370 - 437 IPR013098

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
PANTHER Family PTHR24342 SERINE/THREONINE-PROTEIN KINASE 17
PANTHER Subfamily PTHR24342:SF15 DEATH-ASSOCIATED PROTEIN KINASE 2
PANTHER Protein Class non-receptor serine/threonine protein kinase
protein modifying enzyme
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

2 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
protein kinase activity Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction

No GO annotations of biological process

Name Definition
No GO annotations for biological process

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
IKLLGRKVRG KHDGPKINDY DKFYEDIWKK YVPQPVEVKQ GSCYDYYDIL EELGSGAFGV
70 80 90 100 110 120
VHRCVEKATG RVFEAKFINT PYPLDKYTVK NEISIMNQLH HPKLINLHDA FEDKYDMVLI
130 140 150 160 170 180
LEFLSGGELF DRIAAEDYKM SEAEVINYMR QACEGLKHMH EHSIVHLDIK PENIMCETKK
190 200 210 220 230 240
ASSVKIIDFG LATKLNPDEI VKVTTATAEF AAPEIVDREP VGFYTDMWAI GVLGYVLLSG
250 260 270 280 290 300
LSPFAGEDDL ETLQNVKRCD WEFDEDAFSS VSPEAKDFIK NLLQKEPRKR LTVHDALEHP
310 320 330 340 350 360
WLKGDHSNLT SRIPSSRYNK IRQKIKEKYA DWPAPQPAIG RIANFSSLRK HRPQEYQIYD
370 380 390 400 410 420
SYFDRKEAVP RFVRRPRNQI TADESAKFDC KIIAASPPIV TWYKDDGLLG QSYKHMHKYH
430 440 450
GSEYELKISR IKMDDKGAAR EKSIRTKSKV D